App-Quantinova.ai

IS ABLATION OF ATRIAL FLUTTER RECOMMENDED IN ELDERLY PATIENTS?

Beatrice Brembilla-Perrot - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

EVALUATION OF DOFETILIDE INITIATION ALGORITHM: A SINGLE CENTER EXPERIENCE

Madhu Reddy - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

Dofetilide

THE EFFECT OF LEFT VENTRICULAR SENSING ELECTRODE POSITION ON ELECTRICAL DELAY IN CARDIAC RESYNCHRONIZATION THERAPY

Peter Netzler - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

SURVIVAL BENEFIT OF THE PRIMARY PREVENTION IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR AMONG OLDER PATIENTS: DOES AGE MATTER? A PATIENT-LEVEL META-ANALYSIS OF 5 CLINICAL TRIALS

Paul L. Hess - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

THE APPROPRIATENESS USE CRITERIA FOR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) AND CARDIAC RESYNCHRONIZATION THERAPY (CRT) EVIDENCE BASED OR CONSENSUS DRIVEN?

Sendil Kumar Hari Prasad - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

OUTCOME FOLLOWING ICD IMPLANTATION WITH VERSUS WITHOUT DEFIBRILLATION TESTING: PRELIMINARY RESULTS OF THE PROSPECTIVE RANDOMIZED TEST-NO TEST (TNT) PILOT STUDY

Andrea Russo - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

THE RATIO OF LEFT VENTRICULAR END SYSTOLIC VOLUME INDEX AND QRS DURATION IS A POTENT PREDICTOR OF RESPONSE IN PATIENTS WITH A LBBB UNDERGOING CARDIAC RESYNCHRONIZATION THERAPY

Jack Rickard - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

EFFECT OF INTRINSIC QRS MORPHOLOGY ON LONG-TERM RESULT IN RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY

Koichi Inoue - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

LONG-TERM OUTCOMES AND RISK FACTORS FOR AORTIC VALVE DYSFUNCTION AFTER DISCRETE SUBVALVAR AORTIC STENOSIS RESECTION IN CHILDREN

Sarah Pickard - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

MAIN PULMONARY ARTERY AREA LIMITS EXERCISE CAPACITY IN PATIENTS LONG-TERM AFTER ARTERIAL SWITCH OPERATION FOR TRANSPOSITION OF THE GREAT ARTERIES (TGA)

Mieke MP Driessen - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Heart muscle disease

N/A

HEMODYNAMIC CAUSES FOR EXERCISE INTOLERANCE IN FONTAN PATIENTS

Anders Hedeboe Hebert - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Heart muscle disease

N/A

BIVENTRICULAR STRAIN AND DYSSYNCHRONY IN REPAIRED TETRALOGY OF FALLOT: RELATIONSHIP TO DEATH AND SUSTAINED VENTRICULAR TACHYCARDIA MEASURED BY CARDIAC MAGNETIC RESONANCE

Thomas Moon - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

HYPERTROPHIC CARDIOMYOPATHY CENTER: CONTEMPORARY MULTIDISCIPLINARY GUIDELINE-BASED EXPERIENCE

Anushree Agarwal - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Heart muscle disease

disopyramide

ASSOCIATION BETWEEN FUNCTIONAL OUTCOME AND VENTRICULAR MECHANICS IN EISENMENGER SYNDROME: A SPECKLE TRACKING STUDY

Krong-On Pinyoluksana - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

SPORTS FOR YOUNG PATIENTS WITH IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS: REFINING THE RISK

Elizabeth Saarel - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

CHARACTERISTICS, TREATMENTS, AND OUTCOMES OF HOSPITALIZED HEART FAILURE PATIENTS STRATIFIED BY ETIOLOGIES OF NON-ISCHEMIC CARDIOMYOPATHY

Supriya Shore - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

LEFT VENTRICULAR ASSIST DEVICE THERAPY IN PATIENTS WITH ADULT CONGENITAL HEART DISEASE

Melissa Lyle - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Heart muscle disease

N/A

SYSTOLIC TO DIASTOLIC DURATION RATIO AND EXERCISE STRESS RESPONSE IN 150 CHILDREN WITH AND WITHOUT HEART DISEASE: A TISSUE DOPPLER STRESS ECHOCARDIOGRAM STUDY

Linda B. Pauliks - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

IMPLANTABLE CARDIOVERTER DEFIBRILLATOR OUTCOMES IN PEDIATRIC AND CONGENITAL HEART DISEASE: I-S COMPLICATED

Brynn Dechert - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

CHRONIC MITRAL REGURGITATION: WHEN SHOULD WE INTERVENE IN ASYMPTOMATIC CHILDREN?

Joyce Johnson - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Filters

3340 Abstracts